Silver Book Fact

Fact image

New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer

PhRMA. The Value of Medicines: Facts and figures 2006; 2006. http://innovation.org/documents/Value%20of%20Medicine%20FINAL%200712061.pdf

Reference

Title
The Value of Medicines: Facts and figures 2006
Publication Date
2006
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Improvements in surgical techniques and combination therapies increased the 1-year survival rate for lung cancer from 34 percent in 1975-1977 to 45 percent in 2006-2009.  
  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.  
  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.  
  • Following the current path, the colon cancer incidence rate will increase by 31.8% between 2003 and 2023 (447,000 people). If an alternative path is taken, there will be 17.7% (79,000…  
  • Chemotherapy drugs now target specific genomic abnormalities, about 150 effective drugs are available for cancer therapy, and new surgical techniques minimize negative consequences while producing better results.